Evidence map›Paper›PMID 35186747›Full record

ArticleFrontiers in oncology2022

A Multi-Compartment Model of Glioma Response to Fractionated Radiation Therapy Parameterized

Junyan Liu, David A Hormuth, Jianchen Yang, Thomas E Yankeelov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Junyan LiuDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
David A HormuthOden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin, TX, United States.
Jianchen YangDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Thomas E YankeelovDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
The University of Texas at Austin · USLivestrong Foundation · USThe University of Texas MD Anderson Cancer Center · US

Funding

Quantitative Multiscale Imaging to Optimize Cancer Treatment StrategiesR01CA186193 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO, RERICHA, ERIN C · 2014 to 2019
$3.1M
Clinical Development of Rhenium Nanoliposomes (RNL186) for GlioblastomaR01CA235800 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BRENNER, ANDREW JACOB · 2019 to 2023
$3.0M
Using label-free Raman microscopy to predict therapeutic resistance of TNBC cellsU01CA253540 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI BROCK, AMY, YANKEELOV, THOMAS E · 2020 to 2024
$2.1M
Personalizing immunotherapy in HER2+ breast cancer through quantitative imagingR01CA240589 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SORACE, ANNA C · 2020 to 2023
$1.6M
NCI NIH HHS R01 CA186193NCI NIH HHS R01 CA235800NCI NIH HHS R01 CA240589NCI NIH HHS U01 CA253540
6 · The paper itself

Abstract

purposeConventional radiobiology models, including the linear-quadratic model, do not explicitly account for the temporal effects of radiation, thereby making it difficult to make time-resolved predictions of tumor response to fractionated radiation. To overcome this limitation, we propose and validate an experimental-computational approach that predicts the changes in cell number over time in response to fractionated radiation.

methodsWe irradiated 9L and C6 glioma cells with six different fractionation schemes yielding a total dose of either 16 Gy or 20 Gy, and then observed their response

resultsFor the 9L cells, we observed PCCs and CCCs between the model predictions and validation data of (mean ± standard error) 0.96 ± 0.007 and 0.88 ± 0.013, respectively, across all fractionation schemes. For the C6 cells, we observed PCCs and CCCs between model predictions and the validation data were 0.89 ± 0.008 and 0.75 ± 0.017, respectively, across all fractionation schemes.

conclusionBy proposing a time-resolved mathematical model of fractionated radiation response that can be experimentally verified

Indexed as

brain cancer cellcomputational biologygliomamathematical modelingoncologyradiobiology

Identifiers

PMID35186747
PMCPMC8855115
OpenAlexW4210658288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.